Caplin Point Laboratories Limited
In PositoAI's records, Caplin Point Laboratories Limited has had 12 dividends since 2021 (₹30.5 per share in total). Latest dividend: ₹4 per share, ex-date 18 Sep 2026.
Records start: dividends 2021, bonus and rights issues 2016, splits and buybacks 2022, mergers and demergers 2025. Earlier actions are not shown.
Caplin Point Laboratories Limited Dividend History#
| Ex-date | Dividend |
|---|---|
| 2026 | ₹8 per share (2 payments) |
| 29 May 2026 | ₹4 per share |
| 18 Sep 2026 | ₹4 per share |
| 2025 | ₹6 per share (2 payments) |
| 30 May 2025 | ₹3 per share |
| 12 Sep 2025 | ₹3 per share |
| 2024 | ₹5 per share (2 payments) |
| 31 May 2024 | ₹2.5 per share |
| 23 Sep 2024 | ₹2.5 per share |
| 2023 | ₹4.5 per share (2 payments) |
| 9 Jun 2023 | ₹2 per share |
| 14 Sep 2023 | ₹2.5 per share |
| 2022 | ₹4 per share (2 payments) |
| 23 May 2022 | ₹2 per share |
| 21 Sep 2022 | ₹2 per share |
| 2021 | ₹3 per share (2 payments) |
| 18 May 2021 | ₹1.5 per share |
| 20 Sep 2021 | ₹1.5 per share |
Amounts are per share as declared, not adjusted for later bonus issues or splits.
Questions
Does Caplin Point Laboratories Limited pay dividends?
Yes. In PositoAI's records (from 2021), Caplin Point Laboratories Limited has paid 12 dividends, the latest ₹4 per share with ex-date 18 September 2026.
How much dividend did Caplin Point Laboratories Limited pay in 2025?
₹6 per share in 2025, in 2 payments.
What is an ex-date and a record date?
To receive a dividend, bonus or other benefit, you must own the shares before the ex-date. The record date is the day the company checks its list of shareholders.
Records: dividends from 2021, bonus issues and rights issues from 2016, splits and buybacks from 2022, mergers and demergers from 2025; new actions are added every day. Amounts are per share in rupees. To receive a dividend or bonus, shares must be held before the ex-date. Please confirm dates with the company's own announcement. PositoAI is for research and education only and is not investment advice.